Preanalytical, Analytical, and Computational Factors Affect Homeostasis Model Assessment Estimates
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—We investigated how β-cell function and insulin sensitivity or resistance are affected by the type of blood sample collected or choice of insulin assay and homeostatis model assessment (HOMA) calculator (http://www.dtu.ox.ac.uk). RESEARCH DESIGN AND METHODS—Insulin was measured using 11 different assays in serum and 1 assay in heparinized plasma. Fasting subjects with normoglycemia (n = 12), pre-diabetes, i.e., impaired fasting glucose or impaired glucose tolerance (n = 18), or type 2 diabetes (n = 67) were recruited. Patients treated with insulin or those who were insulin antibody–positive were excluded. HOMA estimates were calculated using specific insulin (SI) or radioimmunoassay (RIA) calculators (version 2.2). RESULTS—All glucose values were within model (HOMA) limits but not all insulin results, as 4.3% were <20 pmol/l and 1% were >300 pmol/l. β-Cell function derived from different insulin assays ranged from 67 to 122% (median) for those with normoglycemia (P = 0.026), from 89 to 138% for those with pre-diabetes (P = 0.990), and from 50 to 81% for those with type 2 diabetes (P < 0.0001). Furthermore, insulin resistance ranged from 0.8 to 2.0 (P = 0.0007), from 1.9 to 3.2 (P = 0.842), and from 1.5 to 2.9 (P < 0.0001), respectively. This twofold variation in HOMA estimates from the various insulin assays studied in serum may be significant metabolically. Insulin was 15% lower in heparinized plasma (used in the original HOMA study) compared with serum, which is now more commonly used. β-Cell function differed by 11% and insulin resistance by 15% when estimates derived from specific insulin were calculated using the RIA rather than the SI calculator. CONCLUSIONS—To enable comparison of HOMA estimates among individuals and different research studies, preanalytical factors and calculator selection should be standardized with insulin assays traceable to an insulin reference method procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019 · cited 1×
“, using a central laboratory with the same methodology throughout (17,18), sample exchanges (19), and ranking HOMA estimates from different assays (20), although these have limited applicability.”
MethodSelf-citationStandardization of insulin immunoassays: report of the American Diabetes Association Workgroup
Marcovina, S., Bowsher, R. R., Miller, W. G., Staten, M., Myers, G., Caudill, S. P., Campbell, S. E., Steffes, M. W., & Workgroup, F. T. I. S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.082214 · Cited by 136 · cited 3×
“cross-reactivity with proinsulins (7).”
BackgroundInfluentialInternational Comparison of C-Peptide Measurements
Wiedmeyer, H.-M., Polonsky, K. S., Myers, G. L., Little, R. R., Greenbaum, C. J., Goldstein, D. E., & Palmer, J. P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081570 · Cited by 42 · cited 1×
“There is no advantage in the use of C-peptide rather than insulin measurements for HOMA, as results from different C-peptide assays vary and Cpeptide is not stable when stored (8).”
Background
Cited by
Selection of the appropriate method for the assessment of insulin resistance
Borai, A., Livingstone, C., Kaddam, I., & Ferns, G. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-158 · Cited by 268
Isokuortti, E., Zhou, Y., Peltonen, M., Bugianesi, E., Clement, K., Bonnefont-Rousselot, D., Lacorte, J.-M., Gastaldelli, A., Schuppan, D., Schattenberg, J. M., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4340-1 · Cited by 120
Toward standardization of insulin immunoassays
Miller, W. G., Thienpont, L. M., Van Uytfanghe, K., Clark, P. M., Lindstedt, P., Nilsson, G., Steffes, M. W., & for the Insulin Standardization Work Group (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118380 · Cited by 111
Self-citationStaten, M. A., Stern, M. P., Miller, W. G., Steffes, M. W., Campbell, S. E., & Workgroup, F. T. I. S. (2010) · Diabetes Care · doi:10.2337/dc09-1206 · Cited by 102
Metadata
- Authors
- Manley, S. E., Luzio, S. D., Stratton, I. M., Wallace, T. M., & Clark, P. M. S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-09-01
- Volume
- 31
- Issue
- 9
- Pages
- 1877-1883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2148072219
- Cited by
- 38
- References
- 4
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.